Mechanical circulatory support —Challenges, strategies, and preparations
ConclusionsHF incidence, prevalence, and undertreatment will grow as a result of new COVID ‐19‐related heart disease. ECMO should be reserved for highly selected cases of COVID‐19 with a reasonable probability of recovery. Special considerations are needed for patients with advanced HF, including those supported by durable LVADs.
Source: Journal of Cardiac Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Wael I. Awad,
Mohamad Bashir Tags: Special Section: Cardiac Surgery Amid COVID 19 Source Type: research
More News: Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | COVID-19 | Heart | Heart Disease | Heart Failure | Heart Transplant | Pandemics | Pneumonia | Psychology | Respiratory Medicine | Transplant Surgery | Transplants